4 completed, 4 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 4, Unknown 4 |
Follow Liver Dysfunction: new trials by email Literature Review of Liver Dysfunction trials Research Report on Liver Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement N acetyl cysteine, normal saline - Oxidative Stress, Liver Dysfunction | Phase 4 | Completed | Kasr El Aini Hospital | 54 | 2024-06-30 | 2025-08-29 |
| Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury Mecobalamin, Ceftriaxone Sodium, Saline - Sepsis, Liver Dysfunction | Phase 4 | Unknown | Sichuan Provincial People's Hospital | 40 | 2024-01-15 | 2024-01-24 |
| Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex sugammadex - Diaphragm Ultrasonography, Liver Dysfunction | Phase 4 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 99 | 2021-07-01 | 2021-09-05 |
| Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion Advagraf - Liver Dysfunction | Phase 4 | Unknown | Seoul National University Hospital | 60 | 2016-07-01 | 2016-08-31 |
| Temocillin Pharmacokinetics in Paediatrics Temocillin - Infection, Liver Dysfunction | Phase 4 | Unknown | Université Catholique de Louvain | 45 | 2016-02-17 | 2022-05-31 |
| Octaplas Pediatric Plasma Replacement Trial octaplas - Liver Surgery, Liver Dysfunction | Phase 4 | Completed | Octapharma | 50 | 2014-12-01 | 2020-06-23 |
| Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide) Mitiglinide - Type 2 Diabetes Mellitus, Liver Dysfunction | Phase 4 | Completed | Orient Europharma Co., Ltd. | 16 | 2014-02-11 | 2021-04-30 |
| Liver Function After Intravenous Methylprednisolone Administration every week IVMP therapy, very high doses IVMP therapy - Graves Disease, Graves Ophthalmopathy | Phase 4 | Completed | Medical University of Warsaw | 68 | 2012-01-01 | 2018-09-13 |
Liver Diseases (8) · Chemical and Drug Induced Liver Injury (1) · Diabetes Mellitus, Type 2 (1) · Graves Disease (1) · Graves Ophthalmopathy (1) · Hemostatic Disorders (1) · Hepatic Insufficiency (1) · Infections (1) · Liver Failure (1) · Liver Failure, Acute (1) · Sepsis (1) · Urinary Tract Infections (1)
Digestive System Diseases (8) · Endocrine System Diseases (2) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Chemically-Induced Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Diabetes Mellitus (1) · Drug-Related Side Effects and Adverse Reactions (1) · Exophthalmos (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Glucose Metabolism Disorders (1)
Acetylcysteine (1) · Ceftriaxone (1) · Saline Solution (1) · Sodium Chloride (1) · Sugammadex (1) · Tacrolimus (1) · mecobalamin (1) · mitiglinide (1) · temocillin (1)
Kasr El Aini Hospital (1) · Medical University of Warsaw (1) · Octapharma (1) · Orient Europharma Co., Ltd. (1) · Seoul National University Hospital (1) · Sichuan Provincial People's Hospital (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Université Catholique de Louvain (1)
China (2) · Belgium (1) · Egypt (1) · South Korea (1) · Taiwan (1) · United States (1)
Chun Pan, ph.D (1) · Kwang-Woong Lee, Dr. (1) · Wei-Ming Chen, MD (1) · Wolfgang Frenzel (1) · Yi-Hsiang Huang, Ph.D (1) · Yun Lin, MD, PhD. (1)
PMID 30420883, PMID 32911703, PMID 33042916, PMID 35105573, PMID 38686365